You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
金斯瑞生物科技(01548.HK)附属发布两项研究之最新资料
阿思达克 11-05 09:21
金斯瑞生物科技(01548.HK)公布,附属子公司传奇生物科技在第62届美国血液学会(「ASH」)年会将分别公布CARTITUDE-1和LEGEND-2两项研究的最新资料。ASH年会将於2020年12月5日至12月8日通过虚拟会议举行。

口头报告期间将展示CARTITUDE-1的某些更新资料,重点介绍靶向B细胞成熟抗原(BCMA)的嵌合抗原受体T细胞(「CAR-T」)疗法(西达基奥仑赛,CiltacabtageneAutoleucel;cilta-cel)在治疗复发或难治性多发性骨髓瘤的1b/2期临床研究中的疗效和安全性结果。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account